ALLMedicine™ Mitral Regurgitation Center

Jan 24th, 2022 - Functional mitral regurgitation(FMR) in patients with cardiomyopathy correlates with morbidity and mortality in heart failure. The response of FMR to cardiac resynchronization therapy(CRT) varies. The aim of our study was to analyze the incidence ...

Jan 22nd, 2022 - Pulmonary hypertension (PH), right ventricular (RV) dysfunction, and tricuspid regurgitation (TR) are commonly present in patients with mitral regurgitation (MR) and known to impair prognosis. This systematic review and meta-analysis aimed to dete...

Jan 22nd, 2022 - Mitral valve transcatheter edge-to-edge repair (TEER) is becoming increasingly common to treat severe mitral regurgitation. However, the lack of concomitant annuloplasty raises concerns regarding its durability. As a result, there is an emerging b...

Jan 21st, 2022 - This study aimed to investigate the role of secondary mitral regurgitation (MR) and tricuspid regurgitation (TR) in the pathogenesis of cardiorenal syndrome (CRS). Worsening renal function in patients with acute decompensated heart failure receivi...

Jan 20th, 2022 - Evidence regarding redo percutaneous interventions for recurrent mitral regurgitation is scarce. We ought to evaluate procedural and clinical outcomes of repeated edge-to-edge transcatheter mitral valve repair (TMVR) interventions. This multicente...

Feb 19th, 2020 - Mitral regurgitation (MR) is a complex valve lesion that can pose significant management challenges. This expert consensus decision pathway emphasizes that recognition of MR should prompt an assessment of its etiology, mechanism, and severity, as ...

Feb 10th, 2020 - In this update, we focus on selected topics of high clinical relevance for health care providers who treat patients with heart failure (HF), on the basis of clinical trials published after 2017. Our objective was to review the evidence, and provid...

Feb 18th, 2014 - Transcatheter therapies for mitral regurgitation: a professional society overview from the American College of Cardiology, The American Association for Thoracic Surgery, Society for Cardiovascular Angiography and Interventions Foundation, and The ...

Sep 12th, 2013 - The interventional treatment of mitral valve regurgitation by the MitraClip procedure has grown rapidly in Germany and Europe during the past years. The MitraClip procedure has the potential to treat high-risk patients with secondary mitral valve ...

Jan 19th, 2022 - Study to assess the feasibility, safety, and performance of the HighLife CLARITY TSMV, and its deliver systems, in NYHA Class ≥ II-IV patients with moderate-severe or severe mitral regurgitation who are at high risk for surgical treatment accordin...

Jan 19th, 2022 - to evaluate the feasibility, safety and performance of the HighLife 28mm Transcatheter Mitral Valve in patients with moderate-severe or severe mitral regurgitation who are at high risk for surgical treatment.

Jan 11th, 2022 - This study is a prospective, single-arm, multi-center feasibility clinical study of the Tendyne Mitral Valve System for the treatment of eligible subjects with symptomatic, severe mitral regurgitation and severe mitral annular calcification (MAC)....

Jan 6th, 2022 - Background: The investigator team had focused on heart failure (HF) treatment for many years and tried to develop non-invasive guide for HF treatment. Initially, the investigators had dedicated to use echocardiography to simulate Swan-Ganz and per...

Jan 6th, 2022 - The purpose of this study is to evaluate the safety and performance of the Tendyne Mitral Valve System in the treatment of severe mitral regurgitation in patents with functional disability greater than or equal to NYHA Class II, who are not suitab...

Dec 13th, 2021 - A new Society of Thoracic Surgeons–American College of Cardiology Transcatheter Valve Therapy (STS-ACC-TVT) Registry offers an up-to-date systematic review of transcatheter mitral valve therapy in the United States. Registry data show significant ...

Nov 30th, 2021 - A 67-year-old man with a history of hypertension and mild mitral regurgitation (treated with a beta-blocker and hydrochlorothiazide) presents to the emergency department because of intermittent palpitations and shortness of breath. His physical ex...

Nov 23rd, 2021 - The positive effect of transapical transcatheter mitral valve replacement (TMVR) in patients with severe symptomatic mitral regurgitation (MR) is sustained at 2 years, according to follow-up data on the first 100 patients from the Expanded Clinica...

Nov 13th, 2021 - Tricuspid valve repair at the time of mitral-valve surgery reduces tricuspid regurgitation progression but at the cost of more than a 5-fold increase in permanent pacemakers, a new Cardiothoracic Surgical Trials Network study shows. The results we...

Nov 9th, 2021 - It remains early days for transcatheter mitral-valve replacement (TMVR) as a minimally invasive way to treat severe, mitral regurgitation (MR), but it's even earlier days for TMVR as an endovascular procedure. Most of the technique's limited exper...